InvestorsHub Logo
Followers 19
Posts 399
Boards Moderated 0
Alias Born 04/15/2008

Re: masshysteria post# 237704

Sunday, 10/04/2015 11:49:58 AM

Sunday, October 04, 2015 11:49:58 AM

Post# of 345756
That is why I find it so interesting that David Berman, who headed up I/O for BMS left a lucrative career path and jumped ship to head I/O for Medimmune/AZN. Within months they announced combo trials, one of which is with PPHM's Bavi. Why would someone with the deep knowledge he has of Yervoy/Nivo jump ship and almost right away sign up combo trials? If BMS was outdistancing everyone would he have made the move? Time will tell.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News